Similarly, for 1% increase in ALT change, the odds of progression increased by a factor of 1.01, 1.03, 1.04, and 1.03 for fibrosis score, NAS, NASH, and NASH + fibrosis respectively. Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.